Among cardiovascular risk factors, hypertension appears to longitudinally amplify the potency of plasma NfL as a blood biomarker for neurodegeneration and clinical progression in older adults without dementia (Table 2, Supplementary Table 6, and Fig. 3B). Here, NEFL is linked to hypertensive disorder.